The website domain reflects its role for my own purpose only. Viewing of the webpages by others is not approved.
Main Index Site Developments
Patient Information Conditions of Use



---
Myocardial Infarction
Optimising Drug Therapy

Ace-inhibitors after Myocardial Infarction.

The evidence in favour of ace-inhibitor therapy after myocardial infarction is compelling.

  • Patients with significant left ventricular impairment or with heart failure get large benefits from these agents- these agents reduce mortality, reduce admissions to hospital with heart failure, and reduce adverse left ventricular remodelling after infarction.
  • There is evidence that maximal ace-inhibitor therapy provides additional benefits to moderate dosage ace-inhibitor therapy.
  • However, there will be some patients in whom we wish to start beta-blocker therapy but whose systolic blood pressue is just on 90mmHg. If these patients are on the maximal dose of ace-inhibitor, I think it is reasonable to reduce the dose of ace-inhibitor therapy to enable use of beta-blockers.
  • There is evidence that all patients with atherosclerotic disease should be on ace-inhibitor therapy, including those with good LV systolic function.
Hitesh Patel, Cardiologist
5th June, 2004

Users should read this document on "copyright" and "conditions of use".